HER2-Positive Breast Cancer: Latest Evidence and Guidelines

Scientific Committee

• Demonstration Oncologist AMedical OncologistAcademic Medical Center
• Demonstration Oncologist BMolecular PathologistReference Laboratory

Agenda

1. October 26,Adjuvant and Neoadjuvant HER2-Targeted Therapy

   Updated evidence from recent trials.

2. October 26,Antibody-Drug Conjugates in HER2-Positive Disease

   T-DM1, T-DXd, and emerging ADCs.